Skip to main content

Table 1 Demographic and clinical Data in the study Groups

From: Non-invasive duo positive airway pressure ventilation versus nasal continuous positive airway pressure in preterm infants with respiratory distress syndrome: a randomized controlled trial

Characteristic

DUOPAP

CPAP

P value

Male, n (%)

40(54.1%)

32(43.2)

0.188

Female, n (%)

34(45.9%)

42(56.8)

Cesarean delivery, n (%)

52(70.3%)

57(77%)

0.351

Vaginal delivery, n (%)

22(29.7%)

17(23%)

Gestational age, weeks (mean ± SD)

31.32±1.53

31.13±1.77

0.618

Median (IQR)

31.55(2.1)

31.35(2.8)

Body weight, gr (mean ±SD)

1415±233.15

1377.91±260.24

0.357

Antenatal steroids, n (%) First does

70(94.6%)

68(91.9%)

0.798

Antenatal steroids, n (%) second dose

2(2.7%)

3(4.1%)

Without Antenatal steroids, n (%)

2(2.7%)

3(4.1%)

APGAR 1 min (mean+ SD)

6.15±1.08

6.08±0.89

0.819

Median (IQR)

6(2)

6(2)

APGAR 5 min (mean± SD)

7.69 ±0.79

7.70±0/81

0.928

Median (IQR)

8(1)

8(1)

PPROM, n (%)

12(17.6%)

7(9.6%)

0.161

Age Mother, yrs. (mean ± SD)

Mean IQR

30.08±7.44

29.24±6.59

0.470

Gestational age group, n (%)

 28-30 weeks

12 (16%)

19 (26%)

0.879

 30-32 weeks

34 (46%)

23 (31%)

 

 32-34 weeks

28 (38%)

32 (43%)

 
  1. n number, SD Standard Deviation, IQR Inter Quartile Range